Wanbangde New Building Materials' Mecobalamin Earns FDA Orphan Drug Designation for ALS
CompanyDrug

Wanbangde New Building Materials’ Mecobalamin Earns FDA Orphan Drug Designation for ALS

Biokin Pharmaceutical Registers Phase III Study for BL-B01D1 in EGFR Mutant NSCLC
CompanyDrug

Biokin Pharmaceutical Registers Phase III Study for BL-B01D1 in EGFR Mutant NSCLC

AccurEdit's ART002 Becomes First In Vivo Gene Editing Product to Reduce LDL-C in Humans
CompanyDrug

AccurEdit’s ART002 Becomes First In Vivo Gene Editing Product to Reduce LDL-C in Humans

Beihai Biotech Licenses Beizary to Zydus Lifesciences for US Market
CompanyDeals

Beihai Biotech Licenses Beizary to Zydus Lifesciences for US Market

Huadong Medicine's HDM1005 Shows Positive Results in Phase Ia/Ib Study
CompanyDrug

Huadong Medicine’s HDM1005 Shows Positive Results in Phase Ia/Ib Study

PolyMed Biopharma Licenses HPB-143 to Photys Therapeutics for Global Development
CompanyDeals

PolyMed Biopharma Licenses HPB-143 to Photys Therapeutics for Global Development

Samsung Bioepis' Ospomyv and Xbryk Gain FDA Approval for RANKL Inhibitor Biosimilars
CompanyDrug

Samsung Bioepis’ Ospomyv and Xbryk Gain FDA Approval for RANKL Inhibitor Biosimilars

Kexing Biopharm's GB05 Receives FDA Approval for Pediatric RSV Infections
CompanyDrug

Kexing Biopharm’s GB05 Receives FDA Approval for Pediatric RSV Infections

Sanofi's Merilog Biosimilar Wins FDA Approval for Diabetes Treatment
CompanyDrug

Sanofi’s Merilog Biosimilar Wins FDA Approval for Diabetes Treatment

Yantai Dongcheng's Lannacheng Bio Secures RMB150m to Advance [18F] Spiritide Study
CompanyDeals

Yantai Dongcheng’s Lannacheng Bio Secures RMB150m to Advance [18F] Spiritide Study

GSK's Penmenvy Meningococcal Vaccine Approved by FDA for Ages 10-25
CompanyDrug

GSK’s Penmenvy Meningococcal Vaccine Approved by FDA for Ages 10-25

3SBio and Sichuan Biokin Partner to Advance Solid Tumor Treatment in China
CompanyDeals

3SBio and Sichuan Biokin Partner to Advance Solid Tumor Treatment in China